In clinical practice, G9a mRNA levels were associated with a poor survival rate in lung adenocarcinoma (p = 0.0011), as analyzed using the MatInspector program based on The Cancer Genome Atlas (TCGA) database (Fig 2I) [28]. The gene discussed is EHMT2; the disease is lung adenocarcinoma.